NCT04324359View on ClinicalTrials.gov

Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

March 3, 2020

Primary Completion Date

November 3, 2020

Study Completion Date

November 20, 2020

Conditions
Post-surgical Ocular InflammationPost-surgical Ocular Pain
Interventions
DRUG

SURF-201

One drop twice daily (BID) in the study eye for 16 days.

DRUG

Placebo

One drop twice daily (BID) in the study eye for 16 days.

Trial Locations (10)

12603

Alterman, Modi & Wolter, Poughkeepsie

18704

Eye Care Specialists, Kingston

32204

Levenson Eye Associates, Jacksonville

34613

Hernando Eye Institute, Brooksville

34994

East Florida Eye Institute, Stuart

38120

VRF Eye Specialty Group, Memphis

78229

R and R Eye Research, LLC, San Antonio

78731

Texan Eye Care, PA - Keystone Research, Ltd., Austin

92545

Inland Eye Specialists, Hemet

92562

LoBue Laser and Eye Medical Center, Murrieta

All Listed Sponsors
lead

Surface Ophthalmics, Inc.

INDUSTRY

NCT04324359 - Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects | Biotech Hunter | Biotech Hunter